1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
HIS 1 - LYS 2 OMEGA = 0.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
LYS 2 - CYS 3 OMEGA =359.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
CYS 127 - SER 128 OMEGA = 0.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
SER 128 - SER 129 OMEGA = 0.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
Redfield, C.
Smith, L.J.
Boyd, J.
Lawrence, G.M.P.
Edwards, R.G.
Gershater, C.J.
Smith, R.A.G.
Dobson, C.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
238
23
41
10.1006/jmbi.1994.1265
8145254
Analysis of the solution structure of human interleukin-4 determined by heteronuclear three-dimensional nuclear magnetic resonance techniques.
1994
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
224
899
Human Interleukin 4: The Solution Structure of a Four-Helix-Bundle Protein
1992
US
Biochemistry
BICHAW
0033
0006-2960
30
11029
Secondary Structure and Topology of Human Interleukin 4 in Solution
1991
10.2210/pdb1itm/pdb
pdb_00001itm
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
15120.445
INTERLEUKIN-4
1
man
polymer
no
no
MHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQL
IRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS
MHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQL
IRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1994-05-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1994-02-28
REL
1
BRUNGER
refinement
X-PLOR
MET
0
n
1
MET
0
A
HIS
1
n
2
HIS
1
A
LYS
2
n
3
LYS
2
A
CYS
3
n
4
CYS
3
A
ASP
4
n
5
ASP
4
A
ILE
5
n
6
ILE
5
A
THR
6
n
7
THR
6
A
LEU
7
n
8
LEU
7
A
GLN
8
n
9
GLN
8
A
GLU
9
n
10
GLU
9
A
ILE
10
n
11
ILE
10
A
ILE
11
n
12
ILE
11
A
LYS
12
n
13
LYS
12
A
THR
13
n
14
THR
13
A
LEU
14
n
15
LEU
14
A
ASN
15
n
16
ASN
15
A
SER
16
n
17
SER
16
A
LEU
17
n
18
LEU
17
A
THR
18
n
19
THR
18
A
GLU
19
n
20
GLU
19
A
GLN
20
n
21
GLN
20
A
LYS
21
n
22
LYS
21
A
THR
22
n
23
THR
22
A
LEU
23
n
24
LEU
23
A
CYS
24
n
25
CYS
24
A
THR
25
n
26
THR
25
A
GLU
26
n
27
GLU
26
A
LEU
27
n
28
LEU
27
A
THR
28
n
29
THR
28
A
VAL
29
n
30
VAL
29
A
THR
30
n
31
THR
30
A
ASP
31
n
32
ASP
31
A
ILE
32
n
33
ILE
32
A
PHE
33
n
34
PHE
33
A
ALA
34
n
35
ALA
34
A
ALA
35
n
36
ALA
35
A
SER
36
n
37
SER
36
A
LYS
37
n
38
LYS
37
A
ASN
38
n
39
ASN
38
A
THR
39
n
40
THR
39
A
THR
40
n
41
THR
40
A
GLU
41
n
42
GLU
41
A
LYS
42
n
43
LYS
42
A
GLU
43
n
44
GLU
43
A
THR
44
n
45
THR
44
A
PHE
45
n
46
PHE
45
A
CYS
46
n
47
CYS
46
A
ARG
47
n
48
ARG
47
A
ALA
48
n
49
ALA
48
A
ALA
49
n
50
ALA
49
A
THR
50
n
51
THR
50
A
VAL
51
n
52
VAL
51
A
LEU
52
n
53
LEU
52
A
ARG
53
n
54
ARG
53
A
GLN
54
n
55
GLN
54
A
PHE
55
n
56
PHE
55
A
TYR
56
n
57
TYR
56
A
SER
57
n
58
SER
57
A
HIS
58
n
59
HIS
58
A
HIS
59
n
60
HIS
59
A
GLU
60
n
61
GLU
60
A
LYS
61
n
62
LYS
61
A
ASP
62
n
63
ASP
62
A
THR
63
n
64
THR
63
A
ARG
64
n
65
ARG
64
A
CYS
65
n
66
CYS
65
A
LEU
66
n
67
LEU
66
A
GLY
67
n
68
GLY
67
A
ALA
68
n
69
ALA
68
A
THR
69
n
70
THR
69
A
ALA
70
n
71
ALA
70
A
GLN
71
n
72
GLN
71
A
GLN
72
n
73
GLN
72
A
PHE
73
n
74
PHE
73
A
HIS
74
n
75
HIS
74
A
ARG
75
n
76
ARG
75
A
HIS
76
n
77
HIS
76
A
LYS
77
n
78
LYS
77
A
GLN
78
n
79
GLN
78
A
LEU
79
n
80
LEU
79
A
ILE
80
n
81
ILE
80
A
ARG
81
n
82
ARG
81
A
PHE
82
n
83
PHE
82
A
LEU
83
n
84
LEU
83
A
LYS
84
n
85
LYS
84
A
ARG
85
n
86
ARG
85
A
LEU
86
n
87
LEU
86
A
ASP
87
n
88
ASP
87
A
ARG
88
n
89
ARG
88
A
ASN
89
n
90
ASN
89
A
LEU
90
n
91
LEU
90
A
TRP
91
n
92
TRP
91
A
GLY
92
n
93
GLY
92
A
LEU
93
n
94
LEU
93
A
ALA
94
n
95
ALA
94
A
GLY
95
n
96
GLY
95
A
LEU
96
n
97
LEU
96
A
ASN
97
n
98
ASN
97
A
SER
98
n
99
SER
98
A
CYS
99
n
100
CYS
99
A
PRO
100
n
101
PRO
100
A
VAL
101
n
102
VAL
101
A
LYS
102
n
103
LYS
102
A
GLU
103
n
104
GLU
103
A
ALA
104
n
105
ALA
104
A
ASN
105
n
106
ASN
105
A
GLN
106
n
107
GLN
106
A
SER
107
n
108
SER
107
A
THR
108
n
109
THR
108
A
LEU
109
n
110
LEU
109
A
GLU
110
n
111
GLU
110
A
ASN
111
n
112
ASN
111
A
PHE
112
n
113
PHE
112
A
LEU
113
n
114
LEU
113
A
GLU
114
n
115
GLU
114
A
ARG
115
n
116
ARG
115
A
LEU
116
n
117
LEU
116
A
LYS
117
n
118
LYS
117
A
THR
118
n
119
THR
118
A
ILE
119
n
120
ILE
119
A
MET
120
n
121
MET
120
A
ARG
121
n
122
ARG
121
A
GLU
122
n
123
GLU
122
A
LYS
123
n
124
LYS
123
A
TYR
124
n
125
TYR
124
A
SER
125
n
126
SER
125
A
LYS
126
n
127
LYS
126
A
CYS
127
n
128
CYS
127
A
SER
128
n
129
SER
128
A
SER
129
n
130
SER
129
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
CB
THR
6
WRONG HAND
1
A
A
HG1
H
THR
THR
39
40
1.31
1
A
ARG
47
0.315
SIDE CHAIN
1
A
ARG
53
0.240
SIDE CHAIN
1
A
ARG
64
0.242
SIDE CHAIN
1
A
ARG
75
0.287
SIDE CHAIN
1
A
ARG
81
0.305
SIDE CHAIN
1
A
ARG
85
0.186
SIDE CHAIN
1
A
ARG
88
0.209
SIDE CHAIN
1
A
ARG
115
0.292
SIDE CHAIN
1
A
ARG
121
0.289
SIDE CHAIN
1
21.60
2.70
111.00
132.60
A
A
A
N
CA
C
CYS
CYS
CYS
3
3
3
N
1
-7.39
1.00
110.10
102.71
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
91
91
91
N
1
8.16
0.90
109.00
117.16
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
91
91
91
N
1
7.93
1.10
130.40
138.33
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
91
91
91
N
1
A
LEU
7
-49.37
-70.82
1
A
THR
22
-132.19
-152.22
1
A
THR
28
-18.77
114.71
1
A
ALA
35
-149.03
10.35
1
A
LYS
37
-16.90
-61.58
1
A
THR
39
-126.00
-166.38
1
A
GLU
60
-25.09
-47.96
1
A
THR
63
24.87
52.52
1
A
THR
69
-158.42
-90.30
1
A
ALA
70
-149.42
-51.25
1
A
LEU
96
-128.67
-127.34
1
A
ASN
97
-148.78
-59.51
1
A
PRO
100
-69.69
-179.82
1
A
LYS
102
-111.37
64.29
1
A
GLU
103
-21.15
144.94
1
A
ALA
104
-112.87
-77.87
1
A
LEU
109
3.49
-61.15
1
A
LYS
123
-69.57
2.19
1
A
LYS
126
-95.72
46.14
1
A
CYS
127
-136.13
-36.59
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
ANALYSIS OF THE SOLUTION STRUCTURE OF HUMAN INTERLEUKIN 4 DETERMINED BY HETERONUCLEAR THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE TECHNIQUES
1
Y
N
A
ILE
5
A
ILE
6
HELX_P
A
GLU
19
A
GLU
20
1
H1
15
A
GLU
41
A
GLU
42
HELX_P
A
HIS
59
A
HIS
60
1
H2
19
A
GLN
71
A
GLN
72
HELX_P
A
ALA
94
A
ALA
95
1
H3
24
A
GLU
110
A
GLU
111
HELX_P
A
SER
125
A
SER
126
1
H4
16
disulf
2.019
A
CYS
3
A
SG
CYS
4
1_555
A
CYS
127
A
SG
CYS
128
1_555
disulf
2.020
A
CYS
24
A
SG
CYS
25
1_555
A
CYS
65
A
SG
CYS
66
1_555
disulf
2.019
A
CYS
46
A
SG
CYS
47
1_555
A
CYS
99
A
SG
CYS
100
1_555
CYTOKINE
CYTOKINE
A
HIS
1
A
HIS
2
1
A
LYS
2
A
LYS
3
0.21
A
LYS
2
A
LYS
3
1
A
CYS
3
A
CYS
4
-0.09
A
CYS
127
A
CYS
128
1
A
SER
128
A
SER
129
0.12
A
SER
128
A
SER
129
1
A
SER
129
A
SER
130
0.00
IL4_HUMAN
UNP
1
1
P05112
MGLTSQLLPPLFFLLACAGNFVHGHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFY
SHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS
25
153
1ITM
1
129
P05112
A
1
2
130
2
anti-parallel
A
VAL
29
A
VAL
30
A
ASP
31
A
ASP
32
A
ASN
105
A
ASN
106
A
THR
108
A
THR
109
1
P 1